Growth Metrics

LifeMD (LFMD) Net Income towards Common Stockholders (2016 - 2025)

LifeMD's Net Income towards Common Stockholders history spans 14 years, with the latest figure at $19.2 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 356.46% year-over-year to $19.2 million; the TTM value through Dec 2025 reached $14.1 million, up 150.15%, while the annual FY2025 figure was $11.2 million, 142.8% up from the prior year.
  • Net Income towards Common Stockholders reached $19.2 million in Q4 2025 per LFMD's latest filing, up from -$4.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $19.2 million in Q4 2025 to a low of -$19.0 million in Q4 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$7.4 million, with a median of -$7.5 million recorded in 2023.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 398.08% in 2021, then surged 356.46% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$19.0 million in 2021, then skyrocketed by 33.03% to -$12.7 million in 2022, then soared by 64.53% to -$4.5 million in 2023, then plummeted by 65.94% to -$7.5 million in 2024, then surged by 356.46% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Net Income towards Common Stockholders are $19.2 million (Q4 2025), -$4.6 million (Q3 2025), and $455210.0 (Q2 2025).